Skip to main content

IRLAB-A · IRLAB Therapeutics AB · Insider Trading

1.8200 SEK +0.0160 (+0.89%) At close · Oct 8
Market Cap
268.28M SEK
Shares
148.71M

Transactions in IRLAB Therapeutics AB securities by directors, senior managers and their closely associated persons, as published by the market regulator under the EU Market Abuse Regulation.

Director and related-person transactions

Source-reported director and related-person transactions, including amendments and historical rows. Not a complete insider-ownership register. Coverage is limited to captured publication days; gaps may exist between the first and last day. A verified issuer LEI includes other instruments of that issuer; an ISIN-only match covers that security. Instrument types and transaction descriptions are retained verbatim; do not sum revised, historical or derivative rows as share purchases. Publication timestamps are local source times.

Source-reported transactions from Finansinspektionen, Sweden
Transaction datePersonTransactionInstrumentVolumePriceStatus
2026-07-17 Jan-Fredrik Wilhelm Backman Member of the Board of Directors Allotment 2026/2029:1 Subcription warrant · 1000000 Quantity 0.178 SEK Current Fel val av transaktionskaraktär
2026-07-17 Jan-Fredrik Wilhelm Backman Member of the Board of Directors Acquisition 2026/2029:1 Subcription warrant · 1000000 Quantity 0.178 SEK Revised
2026-07-08 James Gamgort Member of the Board of Directors Acquisition IRLAB Therapeutics AB Share · SE0012675361 10500 Quantity 0.14 USD Current LEI Code Correction
2026-07-07 James Gamgort Member of the Board of Directors Acquisition IRLAB Therapeutics AB Share · SE0012675361 200000 Quantity 0.15 USD Current LEI Code Correction
2026-07-03 Gustaf Albèrt Chief Financial Officer (CFO) Subscription IRLAB Therapeutics AB BTA A BTA · SE0029026145 202631 Quantity 1.2 SEK Current
2026-07-03 Gustaf Albèrt Chief Financial Officer (CFO) Subscription IRLAB Therapeutics A Share · SE0012675361 97369 Quantity 1.2 SEK Current
2026-07-03 Jan-Fredrik Backman Member of the Board of Directors · Related person: Yes Subscription IRLAB Therapeutics AB BTA A BTA · SE0029026145 140716 Quantity 1.2 SEK Current
2026-07-03 Jan-Fredrik Backman Member of the Board of Directors · Related person: Yes Subscription IRLAB Therapeutics A Share · SE0012675361 67618 Quantity 1.2 SEK Current
2026-07-03 Jan-Fredrik Wilhelm Backman Member of the Board of Directors Subscription IRLAB Therapeutics AB BTA A BTA · SE0029026145 112573 Quantity 1.2 SEK Current
2026-07-03 Jan-Fredrik Wilhelm Backman Member of the Board of Directors Subscription IRLAB Therapeutics A Share · SE0012675361 54094 Quantity 1.2 SEK Current
2026-07-01 Carola Elisabet Lemne Chairman of the Board of Directors Subscription IRLAB Therapeutics AB BTA A BTA · SE0029026145 31000 Quantity 1.2 SEK Current
2026-07-01 Kristina Torfgård Chief Executive Officer (CEO)/Managing Directory Subscription IRLAB Therapeutics AB BTA A BTA · SE0029026145 183858 Quantity 1.2 SEK Current
2026-06-30 Carola Elisabet Lemne Chairman of the Board of Directors Subscription IRLAB Therapeutics AB BTA A BTA · SE0029026145 52333 Quantity 1.2 SEK Current
2026-07-01 Joakim Tedroff Other member of the company's administrative, management or supervisory body · Related person: Yes Subscription IRLAB Therapeutics AB BTA A BTA · SE0029026145 4016742 Quantity 1.2 SEK Current
2026-06-26 Nicholas Waters Other member of the company's administrative, management or supervisory body Subscription IRLAB Therapeutics AB BTA A BTA · SE0029026145 250000 Quantity 1.2 SEK Current
2026-06-26 Kristina Torfgård Chief Executive Officer (CEO)/Managing Directory Subscription IRLAB Therapeutics AB BTA A BTA · SE0029026145 66142 Quantity 1.2 SEK Current
2026-06-26 Borkholmen Invest AB Other member of the company's administrative, management or supervisory body Subscription IRLAB BTA A BTA · SE0029026145 427416 Quantity 1.2 SEK Current
2026-06-26 Joakim Tedroff Other member of the company's administrative, management or supervisory body Subscription IRLAB Therapeutics AB BTA A BTA · SE0029026145 555842 Quantity 1.2 SEK Current ISIN-kod
2026-06-26 Joakim Tedroff Other member of the company's administrative, management or supervisory body Subscription IRLAB Therapeutics AB BTA A BTA · SE0025400179 555842 Quantity 1.2 SEK Revised
2025-11-28 Joakim Tedroff Other member of the company's administrative, management or supervisory body · Related person: Yes Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 250000 Quantity 2 SEK Current
2025-11-20 Joakim Tedroff Other member of the company's administrative, management or supervisory body · Related person: Yes Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 70000 Quantity 2 SEK Current
2025-11-12 Joakim Tedroff Other member of the company's administrative, management or supervisory body · Related person: Yes Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 50000 Quantity 2.4 SEK Current
2025-07-25 Carola Elisabet Lemne Chairman of the Board of Directors Subscription IRLAB BTA A BTA · SE0025400179 36000 Quantity 3.5 SEK Current
2025-07-24 Kristina Torfgård Chief Executive Officer (CEO)/Managing Directory Subscription IRLAB BTA A BTA · SE0025400179 75589 Quantity 3.5 SEK Current
2025-07-18 Joakim Tedroff Other member of the company's administrative, management or supervisory body Subscription IRLAB BTA A BTA · SE0025400179 357327 Quantity 3.5 SEK Current
2025-07-17 Joakim Tedroff Other member of the company's administrative, management or supervisory body · Related person: Yes Subscription IRLAB BTA A BTA · SE0025400179 116196 Quantity 3.5 SEK Current
2024-08-05 Kristina Torfgård Chief Executive Officer (CEO)/Managing Directory Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 9000 Quantity 15.65 SEK Current
2024-08-05 Kristina Torfgård Chief Executive Officer (CEO)/Managing Directory Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 4500 Quantity 15.75 SEK Current
2024-07-26 Joakim Tedroff Other senior executive Intra-group transaction decrease IRLAB Therapeutics AB ser. A Share · SE0012675361 154930 Quantity 15.65 SEK Current
2024-07-26 Joakim Tedroff Other senior executive Intra-group transaction increase IRLAB Therapeutics AB ser. A Share · SE0012675361 154930 Quantity 15.65 SEK Current
2024-05-21 Catharina Gustafsson Wallich Member of the Board of Directors Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 8000 Quantity 15.3 SEK Current
2024-05-28 Veronica Wallin Member of the Board of Directors Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 5000 Quantity 15.9 SEK Current
2024-05-21 Carola Elisabet Lemne Chairman of the Board of Directors Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 4000 Quantity 15.55 SEK Current
2024-05-14 Gunnar Olof Olsson Chief Executive Officer (CEO)/Managing Directory Acquisition IRL Share · SE0012675361 2000 Quantity 15.5 SEK Current
2024-05-13 Viktor Siewertz Chief Financial Officer (CFO) Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 5000 Quantity 13.6074 SEK Current
2024-05-10 Daniel Johnsson Member of the Board of Directors Acquisition IRLAB Therapeutics Ab Serie A Share · SE0012675361 20000 Quantity 12.984 SEK Current
2023-04-03 Joakim Tedroff Other senior executive · Related person: Yes Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 51430 Quantity 39.64 SEK Current
2023-02-28 Cecilia Tivert Stenberg Chief Financial Officer (CFO) Disposal IRLAB BTA A Share · SE0013748332 20000 Quantity 10.9 SEK Current
2022-09-01 Richard Godfrey Chief Executive Officer (CEO)/Managing Directory · Related person: Yes Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 5000 Quantity 34.8914 SEK Current
2022-08-30 Viktor Siewertz Chief Financial Officer (CFO) · Related person: Yes Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 40 Quantity 35.5 SEK Current
2022-08-29 Viktor Siewertz Chief Financial Officer (CFO) · Related person: Yes Disposal IRLAB Therapeutics AB ser. A Share · SE0012675361 40 Quantity 35.2 SEK Current
2022-07-15 Joakim Tedroff Other senior executive Division of joint property between spouses decrease IRLAB THERAPEUTICS A Share · SE0012675361 84148 Quantity 0 SEK Current
2022-05-31 Viktor Siewertz Chief Financial Officer (CFO) Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 4500 Quantity 37.86 SEK Current
2022-05-30 Viktor Siewertz Chief Financial Officer (CFO) Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 3000 Quantity 40.16 SEK Current
2022-05-27 Viktor Siewertz Chief Financial Officer (CFO) Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 3000 Quantity 38.93 SEK Current
2022-02-25 Carola Elisabet Lemne Member of the Board of Directors Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 10000 Quantity 32.95 SEK Current ändring av finansiellt instrument till aktie
2022-02-25 Carola Elisabet Lemne Member of the Board of Directors Disposal IRLAB Therapeutics AB ser. A Share · SE0012675361 9000 Quantity 32.1 SEK Current ändrat finansiellt instrument till aktie
2022-02-25 Carola Elisabet Lemne Member of the Board of Directors Acquisition IRLAB Therapeutics BTA A BTA · SE0013748332 10000 Quantity 32.95 SEK Revised
2022-02-25 Carola Elisabet Lemne Member of the Board of Directors Disposal IRLAB Therapeutics BTA A BTA · SE0013748332 9000 Quantity 32.1 SEK Revised
2022-01-19 Gunnar Olof Olsson Chairman of the Board of Directors Acquisition IRLAB Therapeutics AB ser. A Share · SE0012675361 2000 Quantity 37.2 SEK Current

3749 publication days captured; dates between 2016-07-03 and 2026-10-09 may contain gaps. Checked 2026-10-09 22:25 UTC.

Showing 1–50 of 139 transactions